C4d analysis in endomyocardial biopsies of heart transplant patients: Is there a correlation with hemodynamic data?

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1168-1170

  Boffini, M ^a   Ricci, D ^a   Bonato, R ^a   Ribezzo, M ^a   Simonato, E ^a   Saviolo, R ^a   Checco, L ^a   Comoglio, C ^b   Rinaldi, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Villa Maria Pia Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY MEDIATED GRAFT REJECTION; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GOLD STANDARD; GRAFT RECIPIENT; GRAFT REJECTION; HEART CATHETERIZATION; HEART GRAFT; HEART MUSCLE BIOPSY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; COMPLEMENT C4B; ENDOCARDIUM; FEMALE; GRAFT REJECTION; HEART CATHETERIZATION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957623571     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.03.021     Document Type: Conference Paper

References (16)

1. Kfoury AG, Hammond ME: Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant 29:389, 2010
2. Uber WE, Self SE, van Bakel AB, et al: Acute antibody-mediated rejection following heart transplantation. Am J Transpl 7:2064, 2007
3. Batal I, Girnita A, Zeevi A, et al: Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 21:1490, 2008
4. Behr TM, Feucht HE, Richter K, et al: Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18:904, 1999
5. Kirklin JK, Bourge RC, Naftel DC, et al: Is there a need for surveillance endomyocardial biopsies in heart transplantation? Transplant Proc 34:1857, 2002
6. Stewart S, Winters GL, Fishbein MC, et al: Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24:1710, 2005
7. Takemoto SK, Zeevi A, Feng S, et al: National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4:1033, 2004
8. Wasowska BA, Lee CY, Halushka MK, et al: New concepts of complement in allorecognition and graft rejection. Cell Immunol 248:18, 2007
9. Hammond EH, Yowell RL, Nunoda S, et al: Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8:430, 1989
10. Lones MA, Czer LS, Trento A, et al: Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 14:151, 1995
11. Chantranuwat C, Qiao JH, Kobashigawa J, et al: Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence. Immunohistochem Mol Morphol 12:166, 2004
12. Tan CD, Sokos GG, Pidwell DJ, et al: Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 9:2075, 2009
13. Mills RM, Naftel DC, Kirklin JK, et al: Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. J Heart Lung Transplant 16:813, 1997
14. Michaels PJ, Espejo ML, Kobashigawa J, et al: Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22:58, 2003
15. Crespo-Leiro MG, Veiga-Barreiro A, Doménech N, et al: Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 5:2560, 2005
16. Wu GW, Kobashigawa JA, Fishbein MC, et al: Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 28:417, 2009